Court Finds Calls Regarding Medicaid Coverage Not Telemarketing

by Manatt, Phelps & Phillips, LLP
Contact

Manatt, Phelps & Phillips, LLP

A Nevada federal court granted summary judgment in favor of a Telephone Consumer Protection Act (TCPA) defendant after concluding that the plaintiff granted prior express consent to be contacted when she provided her phone number on a hospital registration form.

In July 2014, Charletta Williams obtained medical care at the emergency room at Desert Springs Hospital in Las Vegas, NV. When she arrived, she provided personal information including her name, Social Security number, address, birth date and phone number. After being seen and treated, Williams proceeded to the discharge booth, where she was given paperwork.

One of the documents she signed was a Consent Form that authorized the hospital (and its agents and third-party collection agents) to contact her by the telephone number she provided on her arrival, including the use of prerecorded and autodialed messages.

Over the next few weeks, Williams received five prerecorded calls to her cellphone from Adreima, a third-party contractor with the hospital. Adreima contacts any patients who do not have insurance and/or cannot pay their hospital bills and attempts to help them obtain insurance or assistance for payment (such as through Medicaid). Adreima is paid by the hospital when patients pay their bills.

Williams sued both the hospital and Adreima under the TCPA, arguing that she never consented to receive the calls.

U.S. District Judge Richard F. Boulware undertook a two-part inquiry. Prior express written consent is required for all telemarketing and advertisement calls under the statute. But did Adreima’s calls constitute an advertisement? The TCPA defines an “advertisement” as “any material advertising the commercial availability or quality of any property, goods, or services,” and courts have interpreted this to include “dual purpose” calls, those with both a customer service or informational component and a marketing component.

Williams argued that the contract relationship between the hospital and Adreima transformed the calls into advertising. The defendants objected, relying on the content of the calls—helping individuals sign up for a government program like Medicaid—instead of their relationship.

Agreeing with the defendants, the court found that Adreima’s calls regarding Medicaid and/or charitable health coverage did not constitute “advertising the commercial availability” of any good or service.

“Medicaid is not a ‘commercially available’ program under the plain meaning of that phrase, as it is used to define ‘advertising,’” the court said. “Medicaid is a non-market-based, public program, in which the government of a state subsidizes medical care for only certain citizens who meet specific requirements. It is immaterial that Adreima may be paid when a called customer signs up for Medicaid and Medicaid payments for that person are made to the hospital—the call cannot be an advertising call if it does not promote a commercially available property, good, or service.”

This conclusion was “inform[ed]” by the FCC’s 2015 order that created a medical exigency exception to the TCPA’s requirements, the court added. There, the agency reviewed a petition that asked the FCC to exempt from the prior express consent requirement certain non-telemarketing healthcare calls.

Although the FCC recognized the exigency and public interest in certain categories of healthcare calls (prescription notifications and discharge follow-up calls, for example), it did not include calls regarding account communications and payment notifications. However, the FCC also did not explicitly deny the request as to that type of call either, Judge Boulware said.

“The FCC appeared to articulate a standard for its public policy/exigency exemption, that the call must have a ‘true healthcare treatment purpose,’” the court wrote. “The Court finds that the calls at issue here have a healthcare treatment purpose. It is possible that Medicaid coverage could apply retroactively and cover Plaintiff’s prior treatment, and it is clear that coverage would encourage and enable follow-up treatment and future treatment, and also have the public policy benefit of increasing the likelihood of preventative care.”

Because the calls at issue were not telemarketing calls, prior express consent was sufficient to satisfy the requirements of the TCPA, and the court had little trouble finding the standard was met.

“In light of the limited transactional context of the initial giving of the number upon going to the hospital treatment, the Court finds that Plaintiff consented to calls regarding core treatment issues, as well as to payment for her treatment, and payment for follow-up or future treatment,” the court said. “In the absence of contrary intent, where an uninsured person seeks and receives treatment, it is reasonable to expect that a hospital that has been provided contact information would reach out regarding payment and/or insurance.”

To read the order in Williams v. National Healthcare Review, click here.

Why it matters: The question of what constitutes an “advertisement” is often a tricky one, especially in the context of healthcare-related calls. Here, the court took a close read of the definition of “advertisement” under the statute and concluded that because Medicaid is a non-market-based public program where the government subsidizes medical care for only certain citizens who meet specific requirements, the calls did not constitute advertising or telemarketing under the TCPA. Buoying this position is a 2015 FCC order that created an exemption for certain types of healthcare-related calls.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Manatt, Phelps & Phillips, LLP | Attorney Advertising

Written by:

Manatt, Phelps & Phillips, LLP
Contact
more
less

Manatt, Phelps & Phillips, LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.